CHANCES
Phase 1 Unknown
27 enrolled
PITHAC
Phase 1 Unknown
39 enrolled
Phase I Study to Evaluate Safety and Anti-tumor Activity of PB101, an Anti-angiogenic Immunomodulating Agent
Phase 1 Unknown
30 enrolled
Safety, Tolerability and Pharmacokinetics of Oral CPL304110, in Adult Subjects With Advanced Solid Malignancies
Phase 1 Unknown
42 enrolled
JIVAN
Phase 1 Unknown
30 enrolled
Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced Malignant Solid Tumors
Phase 1 Unknown
36 enrolled
To Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of Disitamab Vedotin Combined With RC98 in the Treatment of Subjects With HER2-expressing Locally Advanced or Metastatic Gastric Cancer (Including AEG)
Phase 1 Unknown
24 enrolled
Minnelide 101
Phase 1 Unknown
66 enrolled
Posterior-line Treatment With Disitamab Vedotin Plus PD-1 in Advanced HER2-low Expressing Gastric Cancer
Phase 1 Unknown
39 enrolled
HER Image
Phase 1 Unknown
6 enrolled
GEN602
Phase 1 Unknown
127 enrolled
A Pilot Study of Neoadjuvant TACiE in Locally Advanced Gastric Cancer
Phase 1 Unknown
20 enrolled
Ph1b Study of Oraxol in Comb. w. Ramucirumab in Patients w. Gastric, Gastro-esophageal, or Esophageal Cancers
Phase 1 Unknown
36 enrolled
Study of SYSA1801 in the Treatment of Claudin( CLDN) 18.2 Positive Advanced Malignant Solid Tumor
Phase 1 Unknown
272 enrolled
Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Using Paclitaxel in Gastric Cancer Patients With Peritoneal Metastasis
Phase 1 Unknown
18 enrolled
Electrochemotherapy for Non-curable Gastric Cancer
Phase 1 Unknown
8 enrolled
A Phase 1 Study of ZSP1241 in Participants With Advanced Solid Tumors
Phase 1 Unknown
90 enrolled
A Phase I Study of High Dose Simvastatin in Patients With Gastrointestinal Tract Cancer Who Failed to Standard Chemotherapy
Phase 1 Unknown
9 enrolled
Haplo / Allogeneic NKG2DL-targeting Chimeric Antigen Receptor-grafted γδ T Cells for Relapsed or Refractory Solid Tumour
Phase 1 Unknown
10 enrolled
Study of Alofanib in Patients With Metastatic Gastric Cancer
Phase 1 Unknown
50 enrolled
Study of EOC317 in Chinese Patients With Advanced Solid Tumors
Phase 1 Unknown
140 enrolled
Nab-paclitaxel Combined With S-1 Treating Diffuse Type of Stage â…¢ Gastric Cancer
Phase 1 Unknown
20 enrolled
da VINci
Phase 1 Unknown
40 enrolled
Intraperitoneal Infusion of EpCAM CAR-T Cell in Advanced Gastric Cancer With Peritoneal Metastasis (WCH-GC-CART)
Phase 1 Unknown
40 enrolled
A Study Evaluating MM-310 in Patients With Solid Tumors
Phase 1 Unknown
34 enrolled
Apatinib in Combination With S-1 as Second-Line Treatment in Patients With Advanced Gastric Cancer
Phase 1 Unknown
12 enrolled
Clinical Safety and Preliminary Efficacy of MUC1-DC-CTL Treatment in Stage IV Gastric Cancer.
Phase 1 Unknown
24 enrolled
A Clinical Research of CAR T Cells Targeting CEA Positive Cancer
Phase 1 Unknown
75 enrolled
A Study of Fluzoparib Given in Combination With Apatinib and Paclitaxel in Gastric Cancer Patients
Phase 1 Unknown
24 enrolled
Study of Metatinib Tromethamine Tablet
Phase 1 Unknown
24 enrolled
Safety Study of GC1118 (Recombinant Human Anti-EGFR Antibody) in Patients With Advanced Solid Cancer
Phase 1 Unknown
72 enrolled
AAV-DC-CTL
Phase 1 Unknown
30 enrolled
LMB-9 Immunotoxin in Treating Patients With Advanced Pancreatic, Esophageal, Stomach, Colon, or Rectal Cancer
Phase 1 Unknown
50 enrolled
SU006668 in Treating Patients With Advanced Solid Tumors
Phase 1 Unknown
Comparison of the Laparoscopy-Assisted Distal Gastrectomy and Open Distal Gastrectomy for Advanced Gastric Cancer
Phase 1 Unknown
124 enrolled
Evaluation of Four Reconstructions After Total Gastrectomy
Phase 1 Unknown
80 enrolled
TIROX
Phase 1 Unknown
23 enrolled